How does the Groww BSE Hospitals ETF differentiate itself from existing healthcare or pharmaceutical-focused passive products, and what specific gap in investor portfolios are you looking to address with a pure-play hospital strategy?
Today, pharma-focused passive funds are a heavy burden on publicly traded pharmaceutical companies, as they should be; even India’s healthcare-focused products can only provide exposure to a broad mix of healthcare companies, including pharmaceutical companies, hospitals and others. The Groww BSE Hospitals ETF, on the other hand, offers targeted exposure to the hospital segment, which accounts for nearly three-quarters of India’s healthcare sector. An important point to note is that pharmaceutical companies often have substantial global exposure and can be influenced by external factors, while hospitals are largely domestic companies and therefore more closely aligned with the structural trends in Indian healthcare demand.By focusing on hospital providers, this ETF seeks to address a portfolio gap for investors seeking pure opportunity in healthcare, one of the fastest growing and rapidly transforming segments in the healthcare ecosystem.
Given that hospitals account for almost three-quarters of the Indian healthcare market and financials are improving, what gives you confidence that this structural growth story can sustain in the next market cycle?
While healthcare as a whole is benefiting from structural tailwinds, the hospital segment has clear drivers that strengthen its long-term growth trajectory. Rising penetration of health insurance, increasing affordability, increased prevalence of lifestyle diseases, medical tourism and a gradually aging population are all expanding the market for organized hospital players.
At the same time, the sector is witnessing continued capacity expansion through rising investments, in addition to improvement in capacity utilization and operational efficiency. Given the long gestation period and high barriers to entry, established players are well positioned to benefit from this increasing demand. India today has a relatively low number of beds per capita and relatively low physician density compared to global counterparts, indicating significant room for potential expansion in the coming years.
As gold and silver see renewed investor interest amid global uncertainties, are you seeing a meaningful shift in retail asset allocation away from equities, or is this more of a tactical diversification trend?
Indians have traditionally invested in precious metals, so the recent surge in flows into gold and silver ETFs should not be seen as a shift away from equities. Rather, it reflects the ongoing financialization of savings, with exposure previously taken through physical gold or silver now shifting to regulated financial instruments.
We view this as a structural evolution in the way allocations are expressed, rather than a short-term tactical shift driven purely by market uncertainty.
In January, gold ETFs saw more inflows than total equity inflows. Is this a sign of increasing euphoria in the precious metals market?
It is not unusual for money flows into an asset class to increase during periods of strong performance. However, if you describe this as euphoria, you may be overstating the matter. While some of the flows could be driven by momentum, gold ETF inflows were already rising before the recent rally.
The category’s assets under management grew more than thirteen times between March 2019 and March 2025, indicating that the trend is structural and long-term in nature, and not purely sentiment-driven.
How should investors think about the allocation between stocks and precious metals right now, especially given high valuations in certain stock markets and strong momentum in gold and silver?
We believe that asset allocation decisions should be guided by long-term strategic frameworks rather than short-term signals of valuation or momentum, and that both equities and precious metals should be part of a diversified portfolio. Stocks remain critical to wealth creation over time, while precious metals can provide diversification benefits, especially during periods of uncertainty.
While stocks tend to be a larger allocation given their link to long-term economic growth, the exact mix should reflect an investor’s risk tolerance, time horizon and financial goals.
For example, how should someone investing in a gold ETF decide which product to buy? Many investors look at returns and expense ratios. What parameters should you look at before selecting an ETF from a particular fund house?
While returns and expense ratios are important, investors should also keep a close eye on tracking error. This reflects how efficiently the ETF reflects underlying gold prices. A lower tracking error indicates better replication, while a higher tracking error can imply a greater deviation from the underlying gold price, leading to inconsistent performance against the commodity it aims to track.
Furthermore, liquidity, in the form of trading volumes and bid-ask spreads, is also a parameter to consider before selecting an ETF.
Many investors also get confused between gold ETFs and gold mutual funds. For someone who already has a demat account and wants to invest for the long term, does it make more sense to buy an ETF than an MF?
Both Gold ETFs and Gold Mutual Funds serve a similar purpose: they provide exposure to gold in a regulated, financial format, and over the long term the difference in returns is likely to be marginal. The choice does not have to materially change the long-term results.
The key distinction lies in structure and convenience: Gold ETFs require a demat account and are traded on the stock exchange like stocks, while Gold Mutual Funds can be purchased and redeemed directly from the AMC without a demat, allowing easier access for certain investors.
#Domestic #healthcare #demand #supports #hospital #ETF #thesis #Groww #CEO